Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCA5 EST90625 ENSG00000154265 ATP-binding cassette, sub-family A (ABC1), member 5 17 69244311-69327244 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA022032 Approved Expressed in all skin: 28.0 ABCB5 ABCB5alpha, ABCB5beta, EST422562 ENSG00000004846 ATP-binding cassette, sub-family B (MDR/TAP), member 5 7 20615207-20777038 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026975 Uncertain Tissue enriched 7 epididymis: 31.7 gallbladder: 4.3 ABCB8 EST328128, M-ABC1, MABC1 ENSG00000197150 ATP-binding cassette, sub-family B (MDR/TAP), member 8 7 151028422-151047782 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045187 Approved Supported Nucleus
Mitochondria Expressed in all thyroid gland: 17.0 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ABCD1 adrenoleukodystrophy, ALD, ALDP, AMN ENSG00000101986 ATP-binding cassette, sub-family D (ALD), member 1 X 153724868-153744762 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all small intestine: 19.7 ABCD3 PMP70, PXMP1, ZWS2 ENSG00000117528 ATP-binding cassette, sub-family D (ALD), member 3 1 94418455-94518666 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032026, HPA032027, CAB032516, CAB075749 Supported Validated Peroxisomes Expressed in all liver: 66.4 ABCD4 EST352188, P70R, PMP69, PXMP1L ENSG00000119688 ATP-binding cassette, sub-family D (ALD), member 4 14 74285423-74303056 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003396 Approved Expressed in all fallopian tube: 13.6 ACKR2 CCBP2, CCR10, CCR9, CMKBR9, D6 ENSG00000144648 Atypical chemokine receptor 2 3 42804752-42887974 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013819, HPA073493 Supported Supported Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 placenta: 22.8 adipose tissue: 5.2 ADCY10 HCA2, RP1-313L4.2, SAC, SACI, Sacy ENSG00000143199 Adenylate cyclase 10 (soluble) 1 167809388-167914215 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015243, HPA017749 Approved Tissue enriched 11 testis: 32.9 liver: 3.1 ADCY3 AC3 ENSG00000138031 Adenylate cyclase 3 2 24819169-24919839 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010223 Approved Expressed in all placenta: 121.3 ADCY7 AC7, KIAA0037 ENSG00000121281 Adenylate cyclase 7 16 50246137-50318135 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041218, HPA048241 Uncertain Approved Cytosol Mixed spleen: 42.9 ADGRE1 EMR1, TM7LN3 ENSG00000174837 Adhesion G protein-coupled receptor E1 19 6887566-6940459 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052809 Uncertain Tissue enhanced 0 appendix: 10.2;spleen: 20.1 lung: 6.8 ADRA2C ADRA2L2, ADRA2RL2, ADRARL2 ENSG00000184160 Adrenoceptor alpha 2C 4 3766348-3768526 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057688 Uncertain Tissue enhanced 0 cervix, uterine: 21.0;endometrium: 26.0;seminal vesicle: 26.7 fallopian tube: 7.9 ALG8 MGC2840 ENSG00000159063 ALG8, alpha-1,3-glucosyltransferase 11 78100936-78139660 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051898 Approved Approved Nucleoplasm Expressed in all testis: 85.6 ANO1 DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A ENSG00000131620 Anoctamin 1, calcium activated chloride channel 11 70078302-70189528 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032148 Supported Tissue enhanced 0 epididymis: 217.7;seminal vesicle: 295.7 skin: 116.0 ANO8 KIAA1623, TMEM16H ENSG00000074855 Anoctamin 8 19 17323223-17334829 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031787, HPA049206 Uncertain Uncertain Nucleoplasm
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 34.6 skin: 20.0 APH1B APH-1B, DKFZp564D0372, PSFL ENSG00000138613 APH1B gamma secretase subunit 15 63276018-63309126 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 testis: 153.1 thyroid gland: 32.0 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065947 Supported Group enriched 8 duodenum: 70.3;small intestine: 50.1 fallopian tube: 7.1 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 AQP7 AQP7L, AQP9, AQPap ENSG00000165269 Aquaporin 7 9 33383179-33402682 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adipose tissue: 315.4 parathyroid gland: 65.5 AQP9 HsT17287, SSC1 ENSG00000103569 Aquaporin 9 15 58138169-58185911 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 appendix: 104.4;liver: 352.6 epididymis: 49.4 ARL6IP1 AIP1, ARL6IP, ARMER, KIAA0069, SPG61 ENSG00000170540 ADP-ribosylation factor-like 6 interacting protein 1 16 18791667-18801678 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045307 Uncertain Approved Endoplasmic reticulum Expressed in all cerebral cortex: 388.0 ARV1 ENSG00000173409 ARV1 homolog, fatty acid homeostasis modulator 1 230978981-231000595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035709 Approved Approved Vesicles Expressed in all testis: 61.6 ATP10D ATPVD, KIAA1487 ENSG00000145246 ATPase, class V, type 10D 4 47485288-47593486 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA050808 Approved Supported Nucleoplasm
Plasma membrane Mixed parathyroid gland: 22.1 ATP11B ATPIF, ATPIR, KIAA0956 ENSG00000058063 ATPase, class VI, type 11B 3 182793500-182921635 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036237, HPA036238 Uncertain Approved Microtubule organizing center
Cytosol Expressed in all testis: 57.7 ATP13A4 DKFZp761I1011, FLJ37958 ENSG00000127249 ATPase type 13A4 3 193402077-193593111 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051932 Approved Nucleoplasm Tissue enhanced 0 epididymis: 89.1;parathyroid gland: 129.5;thyroid gland: 68.2 lung: 56.5 ATP6V0B ATP6F, HATPL, VMA16 ENSG00000117410 ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 1 43974487-43978295 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044281 Approved Cytosol Expressed in all bone marrow: 181.8 ATP7B WND ENSG00000123191 ATPase, Cu++ transporting, beta polypeptide 13 51930436-52012125 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009137, HPA013187 Supported Supported Golgi apparatus Mixed testis: 14.0 C5orf28 FLJ21657 ENSG00000151881 Chromosome 5 open reading frame 28 5 43444252-43483893 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059946 Approved Nucleoplasm Expressed in all thyroid gland: 64.8 CACNA1G Cav3.1, NBR13 ENSG00000006283 Calcium channel, voltage-dependent, T type, alpha 1G subunit 17 50561068-50627474 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA004714 Uncertain Tissue enhanced 0 cerebral cortex: 10.6;cervix, uterine: 8.5 endometrium: 5.2 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supported Tissue enriched 63 testis: 9.7 skin: 0.1 CCKBR ENSG00000110148 Cholecystokinin B receptor 11 6259736-6272127 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 14 cerebral cortex: 13.7;pancreas: 5.4;stomach: 16.1 prostate: 0.8 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CCRL2 ACKR5, CKRX, CRAM-A, CRAM-B, HCR ENSG00000121797 Chemokine (C-C motif) receptor-like 2 3 46407163-46412997 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043238 Approved Mixed lung: 17.7 CD47 IAP, MER6, OA3 ENSG00000196776 CD47 molecule 3 108043298-108091025 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016055, HPA044659 Approved Supported Golgi apparatus
Vesicles
Plasma membrane Expressed in all lung: 204.9 CDIPT PIS, PIS1 ENSG00000103502 CDP-diacylglycerol--inositol 3-phosphatidyltransferase 16 29858357-29863736 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056597 Approved Approved Nucleoplasm
Nuclear membrane
Plasma membrane Expressed in all parathyroid gland: 110.5 CERS1 LAG1, LASS1, UOG1 ENSG00000223802 Ceramide synthase 1 19 18868545-18896727 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045724 Approved Approved Endoplasmic reticulum Group enriched 13 cerebral cortex: 136.6;testis: 28.0 skeletal muscle: 6.5 CH25H ENSG00000138135 Cholesterol 25-hydroxylase 10 89205629-89207314 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed gallbladder: 23.0 CLN6 FLJ20561, HsT18960, nclf ENSG00000128973 Ceroid-lipofuscinosis, neuronal 6, late infantile, variant 15 68206992-68257211 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066046, HPA074162 Approved Approved Vesicles Expressed in all appendix: 23.0 CLPTM1 ENSG00000104853 Cleft lip and palate associated transmembrane protein 1 19 44954585-44993341 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068702 Approved Nuclear membrane
Microtubule organizing center Expressed in all parathyroid gland: 127.5 CMTM1 CKLFH, CKLFH1a, CKLFSF1 ENSG00000089505 CKLF-like MARVEL transmembrane domain containing 1 16 66566393-66579137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013801, HPA017136 Uncertain Approved Nucleoplasm Tissue enriched 6 testis: 28.8 spleen: 4.5 CNGA1 CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49 ENSG00000198515 Cyclic nucleotide gated channel alpha 1 4 47935977-48016672 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA076168 Approved Vesicles
Plasma membrane Mixed liver: 14.2 CNGA2 CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA ENSG00000183862 Cyclic nucleotide gated channel alpha 2 X 151738451-151745304 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at transcript level Evidence at protein level HPA015065 Uncertain Not detected testis: 0.4 CNGA4 CNCA2, CNG5, CNGB2, OCNC2, OCNCb ENSG00000132259 Cyclic nucleotide gated channel alpha 4 11 6234765-6244429 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 9 fallopian tube: 27.6;testis: 10.5 lung: 2.1 CNGB1 CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45 ENSG00000070729 Cyclic nucleotide gated channel beta 1 16 57882340-57971116 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039159, HPA060355 Uncertain Approved Vesicles
Cytosol Mixed appendix: 1.6 CNGB3 ACHM1, ACHM3, RMCH ENSG00000170289 Cyclic nucleotide gated channel beta 3 8 86553977-86743675 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057244 Approved Tissue enhanced 0 testis: 4.0 bone marrow: 2.7 CNNM2 ACDP2 ENSG00000148842 Cyclin and CBS domain divalent metal cation transport mediator 2 10 102918293-103090221 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059954, HPA071631 Validated Vesicles Tissue enhanced 0 parathyroid gland: 33.5 placenta: 12.4 CRHR1 ENSG00000263715 Corticotropin releasing hormone receptor 1 17 45620344-45835826 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enriched 9 cerebral cortex: 1.1 fallopian tube: 0.1 CRLS1 C20orf155, CLS1, dJ967N21.6, GCD10 ENSG00000088766 Cardiolipin synthase 1 20 6006090-6040053 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Expressed in all liver: 86.7 CYB561 CYB561A1, FRRS2 ENSG00000008283 Cytochrome b561 17 63432304-63446378 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014753 Approved Expressed in all adrenal gland: 164.3 CYB561A3 CYBASC3 ENSG00000162144 Cytochrome b561 family, member A3 11 61348745-61362299 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052548 Uncertain Expressed in all adrenal gland: 188.0 CYBRD1 CYB561A2, DCYTB, FLJ23462, FRRS3 ENSG00000071967 Cytochrome b reductase 1 2 171522247-171558133 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014757, HPA056736 Approved Approved Golgi apparatus
Cytosol Expressed in all thyroid gland: 379.4 DAGLB DAGLBETA, KCCR13L ENSG00000164535 Diacylglycerol lipase, beta 7 6409126-6484190 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069377 Supported Plasma membrane Expressed in all cerebral cortex: 20.6 DCSTAMP DC-STAMP, FIND, TM7SF4 ENSG00000164935 Dendrocyte expressed seven transmembrane protein 8 104339087-104356689 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 epididymis: 2.3;lung: 5.6 cervix: 0.4 DEGS1 DEGS-1, Des-1, DES1, FADS7, MLD ENSG00000143753 Delta(4)-desaturase, sphingolipid 1 1 224175756-224193441 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA076422 Supported Mitochondria Expressed in all skin: 617.7 DERL2 CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa ENSG00000072849 Derlin 2 17 5471251-5486811 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037287, HPA048957, HPA056551 Supported Supported Endoplasmic reticulum Expressed in all thyroid gland: 41.3 DERL3 C22orf14, derlin-3, FLJ43842, IZP6, MGC71803 ENSG00000099958 Derlin 3 22 23834503-23839128 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB037234, HPA049306 Uncertain Uncertain Vesicles Mixed stomach: 39.0 DPY19L2 FLJ32949, SPATA34 ENSG00000177990 Dpy-19-like 2 (C. elegans) 12 63558913-63668939 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071264 Approved Nucleus
Mitochondria Tissue enriched 8 testis: 111.5 parathyroid gland: 14.6 DUOXA1 FLJ32334, mol, NIP, NUMBIP ENSG00000140254 Dual oxidase maturation factor 1 15 45117367-45129938 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041578 Approved Tissue enhanced 0 esophagus: 122.6;skin: 107.8;thyroid gland: 111.5 epididymis: 59.7 DUOXA2 ENSG00000140274 Dual oxidase maturation factor 2 15 45114321-45118421 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA063548 Supported Tissue enhanced 0 gallbladder: 97.7;urinary bladder: 25.6 thyroid gland: 13.6 EBP CDPX2, CHO2, CPX, CPXD ENSG00000147155 Emopamil binding protein (sterol isomerase) X 48521158-48528716 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003130 Approved Supported Endoplasmic reticulum Expressed in all liver: 91.1 EDNRA ENSG00000151617 Endothelin receptor type A 4 147480917-147544954 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013774, CAB018957 Uncertain Tissue enhanced 0 seminal vesicle: 145.4 cervix: 82.6 FADS1 D5D, FADS6, FADSD5, LLCDL1, TU12 ENSG00000149485 Fatty acid desaturase 1 11 61799625-61829318 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042705 Approved Expressed in all adrenal gland: 89.6 FADS2 D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13 ENSG00000134824 Fatty acid desaturase 2 11 61792980-61867354 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006741 Approved Expressed in all adrenal gland: 416.6 FADS3 CYB5RP, LLCDL3 ENSG00000221968 Fatty acid desaturase 3 11 61873519-61892051 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045224 Approved Expressed in all adipose tissue: 98.7 FADS6 ENSG00000172782 Fatty acid desaturase 6 17 74877299-74893781 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA016802 Uncertain Tissue enhanced 0 epididymis: 22.6 small intestine: 10.3 FAIM2 KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2 ENSG00000135472 Fas apoptotic inhibitory molecule 2 12 49866896-49904217 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018790, HPA048800 Supported Approved Intermediate filaments Tissue enriched 7 cerebral cortex: 370.8 adrenal gland: 56.0 FAM57A CT120, FLJ22282 ENSG00000167695 Family with sequence similarity 57, member A 17 732412-742972 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 skin: 82.8 esophagus: 26.0 FAM57B DKFZP434I2117 ENSG00000149926 Family with sequence similarity 57, member B 16 30024427-30052978 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030837 Uncertain Group enriched 12 cerebral cortex: 18.7;testis: 77.3 skeletal muscle: 3.9 FAXDC2 C5orf4, FLJ13758 ENSG00000170271 Fatty acid hydroxylase domain containing 2 5 154818491-154859252 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 6 parathyroid gland: 381.3 ovary: 66.6 FFAR4 GPR120, GPR129, O3FAR1, PGR4 ENSG00000186188 Free fatty acid receptor 4 10 93566665-93604480 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042563 Uncertain Uncertain Plasma membrane Tissue enhanced 0 colon: 8.6;rectum: 12.9 lung: 5.5 FITM2 C20orf142, dJ881L22.2, FIT2 ENSG00000197296 Fat storage-inducing transmembrane protein 2 20 44302838-44311169 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 heart muscle: 40.2 parathyroid gland: 23.7 G6PC3 UGRP ENSG00000141349 Glucose 6 phosphatase, catalytic, 3 17 44070735-44076344 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067052 Supported Endoplasmic reticulum Expressed in all epididymis: 82.8 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288082-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supported Tissue enriched 19 cerebral cortex: 88.4 adrenal gland: 4.6 GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA012638, HPA014418, HPA073461 Approved Approved Vesicles Group enriched 7 cerebral cortex: 19.5;colon: 18.0;duodenum: 8.4;rectum: 41.3;small intestine: 19.3;testis: 26.3 appendix: 3.3 GDPD2 FLJ20207, GDE3, OBDPF ENSG00000130055 Glycerophosphodiester phosphodiesterase domain containing 2 X 70423031-70433390 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 skin: 50.9;spleen: 61.0 small intestine: 20.5 GDPD4 GDE6 ENSG00000178795 Glycerophosphodiester phosphodiesterase domain containing 4 11 77216558-77301687 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 7 testis: 4.8 placenta: 0.6 GNRHR GRHR, LHRHR ENSG00000109163 Gonadotropin-releasing hormone receptor 4 67739328-67754360 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA013424 Supported Tissue enhanced 0 parathyroid gland: 1.2 adrenal gland: 1.0 GPR1 ENSG00000183671 G protein-coupled receptor 1 2 206175316-206218047 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA010525 Uncertain Supported Vesicles
Plasma membrane Tissue enhanced 0 placenta: 11.2 esophagus: 5.5 GPR137 C11orf4, GPR137A, TM7SF1L1 ENSG00000173264 G protein-coupled receptor 137 11 64270062-64289500 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062871 Uncertain Approved Nucleus
Nucleoli
Actin filaments Expressed in all testis: 147.8 GPR143 OA1 ENSG00000101850 G protein-coupled receptor 143 X 9725346-9786297 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003648 Approved Mixed skin: 10.3 GRINA HNRGW, LFG1, NMDARA1, TMBIM3 ENSG00000178719 Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) 8 143990058-143993415 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA036980, HPA036981 Approved Approved Nucleoli fibrillar center
Cytosol Expressed in all seminal vesicle: 261.5 HACD1 CAP, PTPLA ENSG00000165996 3-hydroxyacyl-CoA dehydratase 1 10 17589032-17617377 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed heart muscle: 40.1 HACD4 Em:AL662879.1, PTPLAD2 ENSG00000188921 3-hydroxyacyl-CoA dehydratase 4 9 20999515-21031636 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058666 Uncertain Mixed lung: 12.6 HCN1 BCNG-1, BCNG1, HAC-2 ENSG00000164588 Hyperpolarization activated cyclic nucleotide gated potassium channel 1 5 45254950-45696498 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019195 Supported Tissue enriched 7 cerebral cortex: 11.5 heart muscle: 1.7 HCN3 KIAA1535 ENSG00000143630 Hyperpolarization activated cyclic nucleotide gated potassium channel 3 1 155277583-155289848 Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026584 Approved Mixed skin: 3.0 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 1.4;heart muscle: 1.9;testis: 6.7 adrenal gland: 0.5 HHATL C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3 ENSG00000010282 Hedgehog acyltransferase-like 3 42692663-42702827 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018174 Supported Tissue enhanced 0 heart muscle: 333.2;skeletal muscle: 97.6 cerebral cortex: 53.4 HRH4 AXOR35, GPCR105, GPRv53, H4R, HH4R ENSG00000134489 Histamine receptor H4 18 24460629-24479957 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035009 Uncertain Not detected skin: 0.7 HTR2A 5-HT2A, HTR2 ENSG00000102468 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13 46831550-46897076 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014011 Supported Tissue enriched 8 cerebral cortex: 32.3 smooth muscle: 3.8 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium channel, voltage gated shaker related subfamily A, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Approved Tissue enhanced 0 heart muscle: 20.8 esophagus: 5.6 KCNA6 ENSG00000151079 Potassium voltage-gated channel subfamily A member 6 12 4809176-4813412 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level No evidence Evidence at transcript level CAB011539, HPA014418 Approved Not detected lymph node: 0.1 KCNA7 HAK6, Kv1.7 ENSG00000104848 Potassium channel, voltage gated shaker related subfamily A, member 7 19 49067418-49072941 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 37 skeletal muscle: 26.2 esophagus: 0.7 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium channel, voltage gated modifier subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supported Approved Golgi apparatus Tissue enriched 32 cerebral cortex: 37.6 endometrium: 1.1 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium channel, voltage gated eag related subfamily H, member 1 1 210678315-211134115 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014551, HPA019445 Supported Approved Vesicles Tissue enriched 12 cerebral cortex: 11.5 testis: 0.9 KCNH2 erg1, HERG, Kv11.1, LQT2 ENSG00000055118 Potassium channel, voltage gated eag related subfamily H, member 2 7 150944961-150978315 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 bone marrow: 24.1;testis: 27.4 parathyroid gland: 12.9 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium channel, voltage gated eag related subfamily H, member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Approved Nucleus
Mitochondria Group enriched 5 cerebral cortex: 24.3;fallopian tube: 7.1;parathyroid gland: 4.9 adrenal gland: 2.2 KCNH6 erg2, HERG2, Kv11.2 ENSG00000173826 Potassium channel, voltage gated eag related subfamily H, member 6 17 63523334-63548977 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 6.1;prostate: 5.3;small intestine: 5.7 duodenum: 2.3 KCNK15 dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5 ENSG00000124249 Potassium channel, two pore domain subfamily K, member 15 20 44745780-44752313 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA064861 Uncertain Tissue enhanced 0 fallopian tube: 8.0 testis: 2.9 KCNK16 K2p16.1, TALK-1, TALK1 ENSG00000095981 Potassium channel, two pore domain subfamily K, member 16 6 39314698-39322968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 duodenum: 3.9;pancreas: 5.4;stomach: 12.6 thyroid gland: 1.7 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Tissue enhanced 0 lung: 5.6 placenta: 5.2 KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, two pore domain subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 112.3;placenta: 35.5 lung: 19.9 KCNK4 K2p4.1, TRAAK ENSG00000182450 Potassium channel, two pore domain subfamily K, member 4 11 64291302-64300031 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 12 cerebral cortex: 4.3 cervix: 0.3 KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, two pore domain subfamily K, member 6 19 38319844-38332076 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Mixed endometrium: 22.8 KCNK7 K2p7.1 ENSG00000173338 Potassium channel, two pore domain subfamily K, member 7 11 65592855-65595996 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA077577 Approved Plasma membrane Tissue enriched 7 skin: 53.1 esophagus: 8.0 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7 KCNN1 hSK1, KCa2.1 ENSG00000105642 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 19 17951293-18000080 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065938 Approved Actin filaments
Cytosol Tissue enriched 10 cerebral cortex: 21.5 testis: 2.0 KCNN3 hSK3, KCa2.3, SKCA3 ENSG00000143603 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 1 154697455-154870280 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017990, HPA057127 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 25.4 fallopian tube: 9.4 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium channel, voltage gated KQT-like subfamily Q, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supported Tissue enhanced 0 adrenal gland: 134.2;thyroid gland: 102.8 seminal vesicle: 60.3 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium channel, voltage gated KQT-like subfamily Q, member 2 20 63400210-63472677 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Approved Approved Endoplasmic reticulum Tissue enriched 7 cerebral cortex: 56.3 adrenal gland: 8.2 KCNQ3 EBN2, Kv7.3 ENSG00000184156 Potassium channel, voltage gated KQT-like subfamily Q, member 3 8 132120859-132480953 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 26.9 adrenal gland: 1.9 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium channel, voltage gated KQT-like subfamily Q, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 2.5 KCNQ5 Kv7.5 ENSG00000185760 Potassium channel, voltage gated KQT-like subfamily Q, member 5 6 72621792-73198851 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016655 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.4 thyroid gland: 7.8 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, modifier subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.3;gallbladder: 3.8;seminal vesicle: 4.2 testis: 1.7 KCNV1 Kv8.1 ENSG00000164794 Potassium channel, voltage gated modifier subfamily V, member 1 8 109963645-109975847 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 23 cerebral cortex: 21.9 epididymis: 0.9 KCNV2 Kv8.2 ENSG00000168263 Potassium channel, voltage gated modifier subfamily V, member 2 9 2717502-2730037 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031131 Uncertain Tissue enriched 44 testis: 6.6 skin: 0.1 KDELR2 ELP-1, ERD2.2 ENSG00000136240 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 7 6445953-6484242 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016459 Approved Expressed in all placenta: 202.3 LAPTM5 ENSG00000162511 Lysosomal protein transmembrane 5 1 30732469-30757820 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051293 Approved Approved Cytosol Expressed in all bone marrow: 801.2 LMF1 C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A ENSG00000103227 Lipase maturation factor 1 16 853634-981318 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all parathyroid gland: 22.7 MBOAT7 BB1, hMBOA-7, LENG4, LPIAT ENSG00000125505 Membrane bound O-acyltransferase domain containing 7 19 54173412-54189882 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055967 Approved Approved Cytosol Expressed in all cerebral cortex: 24.3 MBTPS2 KFSD, S2P ENSG00000012174 Membrane-bound transcription factor peptidase, site 2 X 21839636-21885424 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA005494, CAB009486 Approved Approved Nucleoplasm
Mitochondria
Cytosol Expressed in all parathyroid gland: 19.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supported Intermediate filaments Mixed rectum: 17.6 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MFSD12 C19orf28, MGC20700, PP3501 ENSG00000161091 Major facilitator superfamily domain containing 12 19 3538261-3574290 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042149, HPA043088 Uncertain Approved Nucleoplasm
Mitochondria Expressed in all skin: 64.2 MFSD6 FLJ20160 ENSG00000151690 Major facilitator superfamily domain containing 6 2 190408355-190509205 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022274 Approved Approved Nucleoplasm
Actin filaments
Cytosol Expressed in all cerebral cortex: 79.2 MLC1 KIAA0027, LVM, MLC, VL ENSG00000100427 Megalencephalic leukoencephalopathy with subcortical cysts 1 22 50059391-50085902 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003040, HPA067533 Supported Tissue enriched 8 cerebral cortex: 181.4 bone marrow: 23.1 MMD2 PAQR10 ENSG00000136297 Monocyte to macrophage differentiation-associated 2 7 4905989-4959213 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 82 cerebral cortex: 41.3;testis: 12.4 adrenal gland: 0.3 MPDU1 CDGIf, Lec35, PQLC5, SL15 ENSG00000129255 Mannose-P-dolichol utilization defect 1 17 7583529-7592789 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014845 Uncertain Supported Endoplasmic reticulum
Mitochondria Expressed in all rectum: 70.2 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 MT-ND6 MTND6, NAD6, ND6 ENSG00000198695 Mitochondrially encoded NADH dehydrogenase 6 MT 14149-14673 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all heart muscle: 21512.1 MYADM ENSG00000179820 Myeloid-associated differentiation marker 19 53866223-53876437 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056301 Approved Nuclear speckles Expressed in all smooth muscle: 257.6 NEMP1 KIAA0286, TMEM194, TMEM194A ENSG00000166881 Nuclear envelope integral membrane protein 1 12 57055643-57088063 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014394 Uncertain Approved Nucleoplasm Mixed lymph node: 14.6 NEMP2 TMEM194B ENSG00000189362 Nuclear envelope integral membrane protein 2 2 190504342-190534722 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA057719 Approved Nucleoplasm Mixed testis: 5.8 NOX4 KOX, KOX-1 ENSG00000086991 NADPH oxidase 4 11 89324356-89498187 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015475 Uncertain Approved Nucleus Tissue enriched 12 kidney: 133.6 parathyroid gland: 10.7 NPC1 ENSG00000141458 Niemann-Pick disease, type C1 18 23506184-23586898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026618, CAB070132 Approved Expressed in all parathyroid gland: 110.9 NPSR1 GPR154, GPRA, PGR14 ENSG00000187258 Neuropeptide S receptor 1 7 34658239-34878332 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA007489 Supported Not detected stomach: 0.5 NRM NRM29 ENSG00000137404 Nurim (nuclear envelope membrane protein) 6 30688047-30691420 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072545, HPA073982 Validated Nuclear membrane Mixed skin: 1.6 OPRM1 MOR1 ENSG00000112038 Opioid receptor, mu 1 6 154010496-154246867 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014509, HPA067435 Supported Supported Tissue enhanced 0 testis: 4.2 esophagus: 1.2 P2RY6 P2Y6 ENSG00000171631 Pyrimidinergic receptor P2Y, G-protein coupled, 6 11 73264505-73298617 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022740 Uncertain Tissue enhanced 0 placenta: 16.8;spleen: 36.2 appendix: 11.0 PARL PRO2207, PSARL, PSARL1, RHBDS1 ENSG00000175193 Presenilin associated, rhomboid-like 3 183829385-183884933 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019545 Approved Supported Mitochondria Expressed in all epididymis: 71.5 PCNXL2 FLJ11383, KIAA0435 ENSG00000135749 Pecanex-like 2 (Drosophila) 1 232983435-233295713 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013815, HPA014427 Uncertain Approved Endoplasmic reticulum Mixed cerebral cortex: 14.0 PGAP2 CWH43-N, FRAG1, MRT21 ENSG00000148985 Post-GPI attachment to proteins 2 11 3797724-3826371 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA063099 Approved Approved Microtubules Expressed in all epididymis: 258.9 PGAP3 CAB2, MGC9753, PER1, PERLD1, PP1498 ENSG00000161395 Post-GPI attachment to proteins 3 17 39671122-39696797 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016591 Approved Approved Plasma membrane
Cytosol Expressed in all thyroid gland: 35.5 PHTF2 DKFZp434D166 ENSG00000006576 Putative homeodomain transcription factor 2 7 77798792-77957503 Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA012312 Uncertain Approved Nucleoplasm
Cytosol Mixed parathyroid gland: 60.8 PIGF ENSG00000151665 Phosphatidylinositol glycan anchor biosynthesis, class F 2 46580937-46617119 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA051389 Uncertain Expressed in all testis: 47.8 PIGO DKFZp434M222, FLJ00135 ENSG00000165282 Phosphatidylinositol glycan anchor biosynthesis, class O 9 35088688-35096601 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014905 Approved Nucleus
Nucleoli Expressed in all parathyroid gland: 73.2 PIGU bA346K17.2, CDC91L1, GAB1 ENSG00000101464 Phosphatidylinositol glycan anchor biosynthesis, class U 20 34560542-34698790 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041706, HPA046766 Uncertain Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 47.2 PLPP4 DPPL2, PPAPDC1, PPAPDC1A ENSG00000203805 Phospholipid phosphatase 4 10 120456954-120589855 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045188 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 17.2;gallbladder: 10.4;testis: 12.7 kidney: 7.7 PLPP5 DPPL1, HTPAP, PPAPDC1B ENSG00000147535 Phospholipid phosphatase 5 8 38263130-38269243 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055777 Approved Vesicles Expressed in all prostate: 123.7 PLPPR2 LPPR2, PRG-4 ENSG00000105520 Phospholipid phosphatase related 2 19 11355386-11365698 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA048973 Uncertain Approved Nucleoplasm Expressed in all cerebral cortex: 77.4 PLPPR3 FLJ11535, LPPR3, PRG-2, PRG2 ENSG00000129951 Phospholipid phosphatase related 3 19 812488-821977 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052293, HPA057034 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 bone marrow: 6.1;cerebral cortex: 9.6;fallopian tube: 8.8 testis: 2.1 POMT1 LGMD2K ENSG00000130714 Protein-O-mannosyltransferase 1 9 131502902-131523806 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065252 Approved Golgi apparatus Expressed in all testis: 62.7 PQLC1 FLJ22378 ENSG00000122490 PQ loop repeat containing 1 18 79902420-79951664 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051666 Uncertain Approved Nucleoplasm Expressed in all adipose tissue: 40.5 PQLC2 FLJ20320 ENSG00000040487 PQ loop repeat containing 2 1 19312326-19329300 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057810 Approved Validated Vesicles Expressed in all testis: 16.3 PROM1 AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4 ENSG00000007062 Prominin 1 4 15963076-16084378 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004922, CAB011525, HPA031053 Approved Tissue enhanced 0 cervix, uterine: 66.8 gallbladder: 47.7 PROM2 ENSG00000155066 Prominin 2 2 95274453-95291308 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046005, HPA063728 Supported Approved Nucleoplasm
Plasma membrane
Cell Junctions Tissue enhanced 0 skin: 71.3 esophagus: 44.8 PTCHD3 FLJ44037, PTR ENSG00000182077 Patched domain containing 3 10 27398187-27414368 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA044613 Supported Tissue enriched 9 testis: 4.1 adipose tissue: 0.4 PTDSS1 KIAA0024, PSS1, PSSA ENSG00000156471 Phosphatidylserine synthase 1 8 96261715-96336995 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016852 Uncertain Approved Nucleoplasm
Endoplasmic reticulum Mixed parathyroid gland: 13.9 QRFPR GPR103 ENSG00000186867 Pyroglutamylated RFamide peptide receptor 4 121329312-121381059 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014300 Uncertain Not detected heart muscle: 0.6 RFT1 CDG1N ENSG00000163933 RFT1 homolog 3 53088483-53130462 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060327 Approved Vesicles Expressed in all testis: 25.8 RGR RP44 ENSG00000148604 Retinal G protein coupled receptor 10 84245053-84259960 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 11 cerebral cortex: 16.1 epididymis: 1.4 RHBDF1 C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1 ENSG00000007384 Rhomboid 5 homolog 1 (Drosophila) 16 58059-76355 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA077399 Uncertain Vesicles Mixed placenta: 39.6 RHBDL1 RHBDL, RRP ENSG00000103269 Rhomboid, veinlet-like 1 (Drosophila) 16 675666-678268 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA030359, HPA030360, HPA046593 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 8.0 adrenal gland: 3.3 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supported Tissue enriched 7 esophagus: 2912.7 tonsil: 436.1 RNF26 MGC2642 ENSG00000173456 Ring finger protein 26 11 119334527-119337313 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027620 Uncertain Approved Nucleoplasm
Vesicles
Cytosol Expressed in all parathyroid gland: 33.3 RP11-294C11.3 ENSG00000279408 15 21651844-21653039 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA057442 Uncertain Uncertain Centrosome Tissue enriched 17 testis: 14.6 cerebral cortex: 0.8 RP5-877J2.1 ENSG00000250424 7 30852273-30923812 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA019206, HPA030130 Approved Approved Plasma membrane Tissue enhanced 0 gallbladder: 1.3 fallopian tube: 1.0 SCD FADS5, SCDOS ENSG00000099194 Stearoyl-CoA desaturase (delta-9-desaturase) 10 100347124-100364834 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012107, HPA063921 Uncertain Validated Endoplasmic reticulum Expressed in all adipose tissue: 1252.9 SCD5 ACOD4, FADS4, FLJ21032, HSCD5, SCD4 ENSG00000145284 Stearoyl-CoA desaturase 5 4 82629539-82798857 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042380 Uncertain Tissue enhanced 0 adrenal gland: 201.7;cerebral cortex: 502.5 epididymis: 117.9 SCN7A NaG, Nav2.1, Nav2.2, SCN6A ENSG00000136546 Sodium channel, voltage gated, type VII alpha subunit 2 166403573-166494247 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004879 Uncertain Tissue enhanced 0 ovary: 63.0 lung: 41.0 SFXN1 FLJ12876 ENSG00000164466 Sideroflexin 1 5 175477062-175529742 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019543, HPA063745 Uncertain Validated Mitochondria Expressed in all liver: 51.5 SFXN2 ENSG00000156398 Sideroflexin 2 10 102714538-102743492 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018150, HPA026834 Supported Approved Mitochondria Tissue enhanced 0 kidney: 18.8 parathyroid gland: 13.2 SFXN4 ENSG00000183605 Sideroflexin 4 10 119140767-119165667 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018028, HPA020872 Approved Supported Vesicles Expressed in all thyroid gland: 47.1 SFXN5 BBG-TCC ENSG00000144040 Sideroflexin 5 2 72942036-73075619 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015473, HPA056866 Approved Approved Nucleoplasm
Mitochondria Tissue enhanced 0 cerebral cortex: 39.5 epididymis: 18.2 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014963 Supported Tissue enhanced 0 duodenum: 70.6;small intestine: 55.4 kidney: 19.6 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supported Tissue enriched 7 kidney: 428.6 placenta: 60.6 SLC14A1 HsT1341, JK, RACH1, RACH2 ENSG00000141469 Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 18 45724127-45752520 Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058353, HPA059570 Supported Supported Vesicles Group enriched 5 prostate: 132.1;urinary bladder: 51.9 cerebral cortex: 18.2 SLC16A10 MCT10, TAT1 ENSG00000112394 Solute carrier family 16 (aromatic amino acid transporter), member 10 6 111087503-111231194 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016860 Approved Approved Vesicles
Cell Junctions Tissue enhanced 0 placenta: 38.2 skin: 22.5 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Expressed in all skeletal muscle: 74.4 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced 0 kidney: 124.3 placenta: 39.9 SLC16A5 MCT5, MCT6 ENSG00000170190 Solute carrier family 16 (monocarboxylate transporter), member 5 17 75087727-75106162 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed duodenum: 35.5 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC1A5 AAAT, ASCT2, M7V1, RDRC ENSG00000105281 Solute carrier family 1 (neutral amino acid transporter), member 5 19 46774883-46788594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035239, HPA035240 Supported Validated Plasma membrane Expressed in all epididymis: 117.4 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supported Tissue enriched 83 kidney: 149.2 seminal vesicle: 1.7 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045015 Uncertain Tissue enriched 46 kidney: 4.6 adipose tissue: 0.0 SLC22A5 CDSP, OCTN2, SCD ENSG00000197375 Solute carrier family 22 (organic cation/carnitine transporter), member 5 5 132369752-132395614 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063062 Approved Mitochondria Mixed parathyroid gland: 31.4 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA019059 Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC25A2 ORNT2 ENSG00000120329 Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 5 141302629-141304045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA042146 Uncertain Tissue enriched 116 testis: 11.6 epididymis: 0.0 SLC25A20 CAC, CACT ENSG00000178537 Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 3 48856931-48898993 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016862, HPA029863 Approved Supported Mitochondria
Cytosol Expressed in all liver: 70.8 SLC25A39 CGI-69, FLJ22407 ENSG00000013306 Solute carrier family 25, member 39 17 44319625-44324870 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026785 Approved Expressed in all bone marrow: 181.5 SLC25A47 C14orf68 ENSG00000140107 Solute carrier family 25, member 47 14 100323337-100330378 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 166 liver: 101.0 duodenum: 0.6 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029893 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all adrenal gland: 34.5 SLC26A7 SUT2 ENSG00000147606 Solute carrier family 26 (anion exchanger), member 7 8 91209494-91398152 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 21 thyroid gland: 548.4 kidney: 26.1 SLC2A11 GLUT10, GLUT11 ENSG00000133460 Solute carrier family 2 (facilitated glucose transporter), member 11 22 23856703-23886309 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042960, HPA071184 Uncertain Uncertain Nucleus
Cell Junctions Mixed parathyroid gland: 10.7 SLC2A5 GLUT5 ENSG00000142583 Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 1 9035107-9088478 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005449 Supported Tissue enhanced 0 duodenum: 112.1;small intestine: 94.6;testis: 139.5 bone marrow: 64.6 SLC2A8 GLUT8, GLUTX1 ENSG00000136856 Solute carrier family 2 (facilitated glucose transporter), member 8 9 127397138-127408424 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011935 Uncertain Approved Vesicles Expressed in all testis: 50.1 SLC2A9 Glut9, GLUTX, URATv1 ENSG00000109667 Solute carrier family 2 (facilitated glucose transporter), member 9 4 9771153-10054936 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066229 Approved Tissue enhanced 0 kidney: 30.9;seminal vesicle: 29.4 duodenum: 11.1 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLC30A5 FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1 ENSG00000145740 Solute carrier family 30 (zinc transporter), member 5 5 69093646-69131069 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035373 Approved Supported Nucleus
Golgi apparatus Expressed in all thyroid gland: 61.6 SLC30A9 C4orf1, GAC63, HUEL, ZNT9 ENSG00000014824 Solute carrier family 30 (zinc transporter), member 9 4 41990472-42090457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004014 Approved Expressed in all parathyroid gland: 35.7 SLC35A1 CMPST, hCST ENSG00000164414 Solute carrier family 35 (CMP-sialic acid transporter), member A1 6 87470623-87512336 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Expressed in all prostate: 59.9 SLC35A3 ENSG00000117620 Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 1 99969789-100026979 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015253 Uncertain Expressed in all rectum: 47.2 SLC35B1 UGTREL1 ENSG00000121073 Solute carrier family 35, member B1 17 49700943-49709014 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048655, HPA057418 Approved Approved Nucleus
Endoplasmic reticulum
Vesicles Expressed in all thyroid gland: 52.0 SLC35D2 SQV7L, UGTrel8 ENSG00000130958 Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 9 96320706-96383710 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA064047 Approved Validated Golgi apparatus Expressed in all small intestine: 73.8 SLC35F5 FLJ22004 ENSG00000115084 Solute carrier family 35, member F5 2 113705011-113756823 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034828, HPA049229 Uncertain Uncertain Plasma membrane Expressed in all thyroid gland: 65.7 SLC38A4 ATA3, NAT3, PAAT ENSG00000139209 Solute carrier family 38, member 4 12 46764761-46832408 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 40 liver: 346.5 smooth muscle: 8.6 SLC38A5 JM24, SN2 ENSG00000017483 Solute carrier family 38, member 5 X 48458537-48470256 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047411 Approved Approved Vesicles
Plasma membrane
Cytosol Mixed pancreas: 50.0 SLC39A14 KIAA0062, NET34, ZIP14 ENSG00000104635 Solute carrier family 39 (zinc transporter), member 14 8 22367249-22434129 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016508 Approved Approved Endoplasmic reticulum
Golgi apparatus
Plasma membrane Mixed liver: 202.8 SLC39A6 LIV-1 ENSG00000141424 Solute carrier family 39 (zinc transporter), member 6 18 36108532-36129385 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042377 Approved Expressed in all prostate: 209.0 SLC39A8 BIGM103 ENSG00000138821 Solute carrier family 39 (zinc transporter), member 8 4 102251041-102431258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA038832, HPA038833 Approved Tissue enhanced 0 lung: 257.1 cervix: 128.6 SLC39A9 FLJ11274 ENSG00000029364 Solute carrier family 39, member 9 14 69398015-69462388 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007921, HPA075390 Approved Approved Endoplasmic reticulum Expressed in all parathyroid gland: 44.1 SLC41A3 FLJ20473 ENSG00000114544 Solute carrier family 41, member 3 3 126006355-126101561 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045847 Approved Supported Plasma membrane Expressed in all testis: 79.0 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Approved Tissue enhanced 0 duodenum: 36.0 prostate: 30.1 SLC45A2 AIM-1, MATP, OCA4 ENSG00000164175 Solute carrier family 45, member 2 5 33944616-33984730 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 skin: 1.2;testis: 1.3 prostate: 0.3 SLC50A1 HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1 ENSG00000169241 Solute carrier family 50 (sugar efflux transporter), member 1 1 155135344-155138857 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018095 Approved Expressed in all epididymis: 133.2 SLC5A6 SMVT ENSG00000138074 Solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2 27199587-27212958 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036958 Approved Approved Cell Junctions Expressed in all epididymis: 82.1 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A2 NAT1, NET, NET1, SLC6A5 ENSG00000103546 Solute carrier family 6 (neurotransmitter transporter), member 2 16 55655604-55706192 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004057, CAB078195 Supported Supported Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 29.4;placenta: 18.2;skin: 15.7 testis: 11.4 SLC6A8 CRTR, CT1 ENSG00000130821 Solute carrier family 6 (neurotransmitter transporter), member 8 X 153688099-153696593 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed small intestine: 90.8 SLC7A6 KIAA0245, LAT-2, LAT3, y+LAT-2 ENSG00000103064 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 16 68264516-68301823 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050713 Uncertain Approved Vesicles
Plasma membrane Mixed adipose tissue: 35.1 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA050818, HPA054671 Supported Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SLC8A3 NCX3 ENSG00000100678 Solute carrier family 8 (sodium/calcium exchanger), member 3 14 70044217-70189070 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 16.3;skeletal muscle: 6.1 adrenal gland: 1.7 SLCO1B3 OATP1B3, OATP8, SLC21A8 ENSG00000111700 Solute carrier organic anion transporter family, member 1B3 12 20810702-20916911 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004943, HPA050892 Supported Supported Plasma membrane Tissue enriched 7 liver: 138.5 cervix: 19.4 SPPL3 DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4 ENSG00000157837 Signal peptide peptidase like 3 12 120762510-120904371 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA004194, HPA059958 Uncertain Supported Vesicles
Plasma membrane Expressed in all parathyroid gland: 82.3 SRD5A1 ENSG00000145545 Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) 5 6633343-6674386 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051402 Approved Mixed skin: 17.1 SRD5A3 FLJ13352, SRD5A2L, SRD5A2L1 ENSG00000128039 Steroid 5 alpha-reductase 3 4 55346109-55373096 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027006 Uncertain Approved Plasma membrane
Cytosol Expressed in all gallbladder: 28.3 STEAP1B ENSG00000105889 STEAP family member 1B 7 22419444-22632925 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 testis: 5.3 spleen: 3.5 SURF4 ERV29, FLJ22993, MGC102753 ENSG00000148248 Surfeit 4 9 133361449-133376166 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064613 Approved Expressed in all small intestine: 84.4 SYVN1 DER3, HRD1 ENSG00000162298 Synovial apoptosis inhibitor 1, synoviolin 11 65121780-65134533 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005480, HPA024300, CAB037030 Supported Supported Nucleoplasm
Endoplasmic reticulum
Plasma membrane Expressed in all tonsil: 76.7 TECR GPSN2, MRT14, SC2, TER ENSG00000099797 Trans-2,3-enoyl-CoA reductase 19 14517085-14565980 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029780, HPA056488 Supported Supported Endoplasmic reticulum Expressed in all parathyroid gland: 397.0 TECRL DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL ENSG00000205678 Trans-2,3-enoyl-CoA reductase-like 4 64275257-64409468 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 18 heart muscle: 361.1 skeletal muscle: 20.5 TLCD1 ENSG00000160606 TLC domain containing 1 17 28724348-28727935 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042366 Approved Mixed fallopian tube: 23.1 TLCD2 ENSG00000185561 TLC domain containing 2 17 1702790-1710438 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA046063 Uncertain Approved Nucleoli
Vesicles Mixed adipose tissue: 6.1 TM4SF1 L6, M3S1 ENSG00000169908 Transmembrane 4 L six family member 1 3 149369022-149377865 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002760, HPA002823 Uncertain Expressed in all gallbladder: 328.4 TM6SF1 ENSG00000136404 Transmembrane 6 superfamily member 1 15 83107407-83144854 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016051, HPA056857 Uncertain Approved Intermediate filaments Mixed thyroid gland: 13.2 TM7SF2 ANG1, DHCR14A, NET47 ENSG00000149809 Transmembrane 7 superfamily member 2 11 65111845-65116384 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA030691, HPA072704 Approved Supported Endoplasmic reticulum
Vesicles Expressed in all adrenal gland: 161.3 TM7SF3 ENSG00000064115 Transmembrane 7 superfamily member 3 12 26973195-27014434 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041097, HPA057640 Uncertain Approved Nucleus
Cytosol Expressed in all kidney: 189.4 TM9SF1 HMP70, MP70 ENSG00000100926 Transmembrane 9 superfamily member 1 14 24189143-24195687 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA059249 Supported Approved Golgi apparatus Expressed in all parathyroid gland: 71.2 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051430 Uncertain Expressed in all spleen: 84.5 TMCO4 DKFZp686C23231 ENSG00000162542 Transmembrane and coiled-coil domains 4 1 19682213-19799945 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014601, HPA014620 Uncertain Approved Endoplasmic reticulum Mixed parathyroid gland: 36.3 TMEM120A NET29, TMPIT ENSG00000189077 Transmembrane protein 120A 7 75986837-75994659 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all small intestine: 73.9 TMEM120B ENSG00000188735 Transmembrane protein 120B 12 121712752-121783001 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014066 Uncertain Mixed endometrium: 12.1 TMEM135 FLJ22104 ENSG00000166575 Transmembrane protein 135 11 87037844-87323758 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA056685, HPA069473 Uncertain Supported Vesicles Expressed in all adipose tissue: 31.8 TMEM147 MGC1936, NIFIE14 ENSG00000105677 Transmembrane protein 147 19 35545595-35547526 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067837 Uncertain Golgi apparatus
Actin filaments
Cytosol Expressed in all thyroid gland: 120.1 TMEM14B MGC1223 ENSG00000137210 Transmembrane protein 14B 6 10747759-10852753 Predicted membrane proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level Expressed in all thyroid gland: 204.2 TMEM150A FLJ90024, TM6P1, TMEM150 ENSG00000168890 Transmembrane protein 150A 2 85598548-85603196 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019015 Uncertain Approved Nucleoplasm
Vesicles Mixed placenta: 33.3 TMEM150B TMEM224 ENSG00000180061 Transmembrane protein 150B 19 55312801-55334048 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 duodenum: 71.8;small intestine: 67.8 lung: 18.9 TMEM161A FLJ20422, FLJ39645 ENSG00000064545 Transmembrane protein 161A 19 19119169-19138513 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043365 Approved Approved Cytosol Expressed in all parathyroid gland: 20.9 TMEM164 FLJ22679, RP13-360B22.2 ENSG00000157600 Transmembrane protein 164 X 110002631-110182734 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA038784 Approved Approved Vesicles
Cell Junctions Expressed in all lung: 26.7 TMEM175 MGC4618 ENSG00000127419 Transmembrane protein 175 4 932387-958656 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057160 Approved Approved Nucleus
Nuclear membrane Expressed in all cerebral cortex: 20.8 TMEM185A CXorf13, FAM11A, FRAXF ENSG00000269556 Transmembrane protein 185A X 149596556-149631912 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048295, HPA071744 Uncertain Approved Endoplasmic reticulum Expressed in all ovary: 36.3 TMEM201 NET5, RP13-15M17.2 ENSG00000188807 Transmembrane protein 201 1 9588922-9614873 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB039039 Approved Supported Nucleus
Nuclear membrane Mixed testis: 9.9 TMEM203 HBEBP1, MGC14327 ENSG00000187713 Transmembrane protein 203 9 137204082-137205638 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Expressed in all cerebral cortex: 39.9 TMEM212 FLJ23172 ENSG00000186329 Transmembrane protein 212 3 171843349-171938715 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045736, HPA053134 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Tissue enriched 6 fallopian tube: 47.9 lung: 7.7 TMEM39B FLJ10315 ENSG00000121775 Transmembrane protein 39B 1 32072031-32102866 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040191, HPA040224 Approved Approved Vesicles Mixed cervix: 9.7 TMEM45A DERP7, FLJ10134 ENSG00000181458 Transmembrane protein 45A 3 100492619-100577444 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA024082, HPA062101 Uncertain Approved Intermediate filaments
Microtubules Tissue enriched 10 skin: 563.8 placenta: 58.1 TMEM62 FLJ23375 ENSG00000137842 Transmembrane protein 62 15 43123279-43185146 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044461, HPA062359 Approved Approved Nucleus
Nucleoli fibrillar center
Nuclear bodies
Cytoplasmic bodies Expressed in all breast: 27.2 TMEM64 DKFZp762C1112 ENSG00000180694 Transmembrane protein 64 8 90621995-90791632 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB034221 Uncertain Expressed in all epididymis: 173.0 TMEM67 JBTS6, MGC26979, MKS3, NPHP11 ENSG00000164953 Transmembrane protein 67 8 93754844-93819234 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039940 Uncertain Tissue enhanced 0 fallopian tube: 21.9 testis: 12.8 TMEM69 C1orf154, FLJ21029 ENSG00000159596 Transmembrane protein 69 1 45687214-45694443 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026993 Approved Approved Nucleoplasm Expressed in all parathyroid gland: 21.9 TMEM79 FLJ16057, FLJ32254, MATT, MGC13102 ENSG00000163472 Transmembrane protein 79 1 156282935-156293185 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA055214 Supported Approved Nucleoli fibrillar center Group enriched 5 esophagus: 61.9;prostate: 45.1;skin: 66.9 tonsil: 11.1 TMEM87A DKFZP564G2022 ENSG00000103978 Transmembrane protein 87A 15 42210452-42273663 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018104, HPA018189 Supported Supported Golgi apparatus Expressed in all prostate: 122.4 TMEM8A M83, TMEM6, TMEM8 ENSG00000129925 Transmembrane protein 8A 16 370773-387113 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051281, HPA064673 Approved Supported Nucleoplasm
Cytokinetic bridge Expressed in all testis: 57.6 TMEM94 KIAA0195 ENSG00000177728 Transmembrane protein 94 17 75441159-75500090 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008423, HPA050660 Approved Supported Nucleoplasm
Nuclear bodies Expressed in all cerebral cortex: 54.3 TMIGD3 AD026 ENSG00000121933 Transmembrane and immunoglobulin domain containing 3 1 111483348-111563962 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 15 testis: 98.4 placenta: 6.5 TMPPE FLJ45032 ENSG00000188167 Transmembrane protein with metallophosphoesterase domain 3 33090421-33096801 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA027019 Uncertain Approved Nucleoplasm
Mitochondria Mixed parathyroid gland: 4.0 TPRA1 FLJ32197, GPR175, TMEM227, TPRA40 ENSG00000163870 Transmembrane protein, adipocyte asscociated 1 3 127573069-127598251 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA019784 Approved Approved Vesicles Expressed in all parathyroid gland: 38.1 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supported Supported Nucleoplasm
Plasma membrane Mixed colon: 27.5 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Approved Nucleoplasm Tissue enriched 7 parathyroid gland: 212.8 thyroid gland: 29.0 TRPM8 ENSG00000144481 Transient receptor potential cation channel, subfamily M, member 8 2 233917398-234019522 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 8 prostate: 128.7 liver: 16.3 TSPAN7 A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 ENSG00000156298 Tetraspanin 7 X 38561370-38688920 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003140, CAB062566, CAB068245 Supported Tissue enriched 6 cerebral cortex: 576.3 adrenal gland: 99.7 TSPO BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS ENSG00000100300 Translocator protein (18kDa) 22 43151514-43163242 Cancer-related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011232, HPA046260 Uncertain Approved Vesicles
Mitochondria
Cytosol Expressed in all bone marrow: 301.2 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023617, HPA050655 Approved Tissue enriched 27 cerebral cortex: 57.9 testis: 2.1 TTYH2 C17orf29 ENSG00000141540 Tweety family member 2 17 74213514-74262020 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 129.6 testis: 21.8 TTYH3 KIAA1691 ENSG00000136295 Tweety family member 3 7 2631951-2664802 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053520 Uncertain Expressed in all cerebral cortex: 62.4 UNC50 GMH1, UNCL, URP ENSG00000115446 Unc-50 homolog (C. elegans) 2 98608579-98618515 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027009 Approved Expressed in all thyroid gland: 105.7 YIF1A 54TM, FinGER7, YIF1, YIF1P ENSG00000174851 Yip1 interacting factor homolog A (S. cerevisiae) 11 66284580-66289170 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014840 Approved Supported Golgi apparatus
Vesicles
Microtubule organizing center Expressed in all thyroid gland: 61.2 YIF1B FinGER8 ENSG00000167645 Yip1 interacting factor homolog B (S. cerevisiae) 19 38305104-38317273 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039328, HPA055257, HPA062675 Approved Approved Golgi apparatus
Vesicles Expressed in all cerebral cortex: 49.6 YIPF1 DJ167A19.1, FinGER1 ENSG00000058799 Yip1 domain family, member 1 1 53851719-53889834 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014716 Approved Approved Nucleoplasm Expressed in all thyroid gland: 42.1 YIPF2 FinGER2, MGC3262 ENSG00000130733 Yip1 domain family, member 2 19 10922185-10928681 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019902 Approved Approved Golgi apparatus
Mitochondria Expressed in all testis: 73.3 YIPF3 C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1 ENSG00000137207 Yip1 domain family, member 3 6 43511827-43516990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014859, HPA063699 Supported Validated Nucleoplasm
Golgi apparatus Expressed in all parathyroid gland: 140.3 YIPF4 FinGER4, MGC11061 ENSG00000119820 Yip1 domain family, member 4 2 32277910-32316594 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017884 Supported Supported Golgi apparatus
Vesicles
Plasma membrane Expressed in all cerebral cortex: 19.0 YIPF5 FinGER5, SMAP-5 ENSG00000145817 Yip1 domain family, member 5 5 144158159-144170714 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042338, HPA073622 Supported Supported Nucleoplasm
Endoplasmic reticulum
Golgi apparatus
Vesicles Expressed in all placenta: 42.9 YIPF6 FinGER6, MGC21416 ENSG00000181704 Yip1 domain family, member 6 X 68498323-68537285 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003720 Uncertain Approved Vesicles Expressed in all thyroid gland: 32.7 ZDHHC11 FLJ13153, ZNF399 ENSG00000188818 Zinc finger, DHHC-type containing 11 5 795606-850986 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057886, HPA069008 Uncertain Approved Lipid droplets Mixed fallopian tube: 10.7 ZDHHC22 C14orf59 ENSG00000177108 Zinc finger, DHHC-type containing 22 14 77131270-77142734 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA072213 Approved Plasma membrane Tissue enriched 57 cerebral cortex: 64.4 epididymis: 1.1 ZDHHC23 MGC42530 ENSG00000184307 Zinc finger, DHHC-type containing 23 3 113947901-113965401 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016808 Uncertain Approved Nucleus Tissue enhanced 0 testis: 15.3 cerebral cortex: 6.2 ZDHHC24 ENSG00000174165 Zinc finger, DHHC-type containing 24 11 66520637-66546238 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016619 Approved Approved Vesicles
Cytosol Mixed parathyroid gland: 10.9 ZDHHC4 FLJ10479, ZNF374 ENSG00000136247 Zinc finger, DHHC-type containing 4 7 6577434-6589374 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA032124, HPA064358 Approved Approved Nuclear bodies Expressed in all thyroid gland: 77.5